← Leaderboards
David Harold Drewry
Univ Of North Carolina Chapel Hill
$3,204,189
Attributed
$5,220,651
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $939.5K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,220,651 · 4
By mechanism
R01$4,898,401 · 2
R03$322,250 · 2
Top collaborators
- Matthew Edward Burow8 shared
- Robert Howard Newman6 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Ryan Balfour Sartor$32,983,163
- Ned Porter$13,848,998
- Terry R Magnuson$26,376,223
- Kurt M. Ribisl$35,707,733
- Jenny P.y. Ting$81,674,016
Others in their field
Other Emerging Leaders on “Signal Pathway”
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Priyamvada Acharya · Duke University$20,941,151
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,867,723
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
Research focus
Signal PathwayMalignant NeoplasmsProteinsOncologyPharmaceutical ChemistryBiological ProcessPathway InteractionsPhosphotransferasesSignal TransductionPathologicDrug DiscoveryBiologicalCancer TherapyCommunitiesMedicineAntineoplastic AgentsDesignPlayCellsProgramsCell MotilityFamilyDrug DevelopmentBiology
Grant awards (12)
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$626,742
R01 · FY2025 · CA · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$595,679
R01 · FY2024 · CA · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$174,596
R01 · FY2024 · CA · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$169,251
R01 · FY2024 · CA · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$614,579
R01 · FY2023 · CA · contact PI
Bivalent degraders of the understudied transcription factor TBXT for the rare cancer chordoma$155,500
R03 · FY2023 · TR · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer (Diversity Supplement - Belgodere)$110,183
R01 · FY2023 · CA · contact PI
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer$636,146
R01 · FY2022 · CA · contact PI
Characterization of an understudied kinase, NEK5, in acquisition of a mesenchymaland migratory cell phenotype$166,750
R03 · FY2020 · TR
Creation of in vivo active chemical probes for CAMKK2 to treat cancer$630,383
R01 · FY2019 · CA · contact PI
Creation of in vivo active chemical probes for CAMKK2 to treat cancer$649,225
R01 · FY2018 · CA · contact PI
Creation of in vivo active chemical probes for CAMKK2 to treat cancer$691,617
R01 · FY2017 · CA · contact PI